NASDAQ:NSPH - Nanosphere Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.69 0.00 (0.00 %) (As of 10/23/2018 05:18 AM ET)Previous Close$1.69Today's Range$1.69 - $1.6952-Week Range$0.48 - $3.64VolumeN/AAverage Volume886,293 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market. Receive NSPH News and Ratings via Email Sign-up to receive the latest news and ratings for NSPH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A SymbolNASDAQ:NSPH CUSIPN/A Webwww.nanosphere.us Phone+1-847-4009000 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-99.68% Return on Equity-232.37% Return on Assets-65.52% Miscellaneous EmployeesN/A Outstanding Shares12,270,000Market Cap$0.00 Nanosphere (NASDAQ:NSPH) Frequently Asked Questions What is Nanosphere's stock symbol? Nanosphere trades on the NASDAQ under the ticker symbol "NSPH." How were Nanosphere's earnings last quarter? Nanosphere, Inc. (NASDAQ:NSPH) posted its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) EPS for the quarter, topping analysts' consensus estimates of ($0.59) by $0.04. The medical research company had revenue of $6.60 million for the quarter, compared to analyst estimates of $6.50 million. Nanosphere had a negative return on equity of 232.37% and a negative net margin of 99.68%. The business's revenue was up 43.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($1.29) earnings per share. View Nanosphere's Earnings History. How do I buy shares of Nanosphere? Shares of NSPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nanosphere's stock price today? One share of NSPH stock can currently be purchased for approximately $1.69. What is Nanosphere's official website? The official website for Nanosphere is http://www.nanosphere.us/. How can I contact Nanosphere? Nanosphere's mailing address is 4088 Commercial Ave, NORTHBROOK, IL 60062-1829, United States. The medical research company can be reached via phone at +1-847-4009000. MarketBeat Community Rating for Nanosphere (NASDAQ NSPH)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 130 (Vote Outperform)Underperform Votes: 122 (Vote Underperform)Total Votes: 252MarketBeat's community ratings are surveys of what our community members think about Nanosphere and other stocks. Vote "Outperform" if you believe NSPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/23/2018 by MarketBeat.com StaffFeatured Article: How Do You Make Money With Penny Stocks?